← Back to Clinical Trials
Recruiting NCT06465628

NCT06465628 Acupressure on Xerostomia in Head and Neck Cancer Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06465628
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Head and Neck Cancer
Study Type INTERVENTIONAL
Enrollment 126 participants
Start Date 2024-12-01
Primary Completion 2026-12-31

Trial Parameters

Condition Head and Neck Cancer
Sponsor The University of Hong Kong
Study Type INTERVENTIONAL
Phase N/A
Enrollment 126
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-12-01
Completion 2026-12-31
Interventions
Self-administered acupressureOral health education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a randomized controlled trial aimed to1) examine the effect of a self-administered acupressure intervention on head and neck cancer patients with xerostomia (primary outcome) relative to oral health education control; 2) examine the effect of self-administered acupressure on secondary outcomes, including quality of life and severity of symptoms of head and neck cancer patients; 3) evaluate patients' expectancy of acupressure; 4) explore the acceptability of self-administered acupressure for head and neck cancer patients with xerostomia. Hypothesis: self-administered acupressure has better effect on xerostomia for head and neck cancer patients comparing to oral health education. Acupressure will also benefit head and neck cancer patients on quality of life and severity of symptoms. Head and neck cancer patients may have good acceptability of self-administered acupressure.

Eligibility Criteria

Inclusion Criteria: * age ≥18 years; * able to give informed consent; * diagnosed with head and neck cancer (cancers in the head and neck region, e.g. oral cancer, nasopharyngeal cancer, oropharyngeal cancer, hypopharyngeal cancer, laryngeal cancer, sinus cancer, salivary gland cancer); * completed radiation therapy or chemoradiotherapy for at least 2 weeks; * complains of xerostomia after the treatment; * able to communicate in Cantonese or Mandarin. Exclusion Criteria: * history of xerostomia prior to head and neck cancer treatment (e.g., Sjögren Syndrome); * practiced acupressure or received acupuncture in the last 3 months; * having contraindications to acupressure, e.g. blood system disease (e.g., leukemia); pregnancy; lactating; upper or lower extremity deformities; infection or injuries at the acupoints. Those who are taking medications/alternative substances to treat xerostomia on a fixed dosage regimen in the past one month will not be excluded. \-

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology